InsidersTradesSigma
Telix Pharmaceuticals Limited: management transactions · Australia · ASX
ASX:telix-pharmaceuticals-limitedAU000000TLX2AU·ASXMcap 3.8Bn€
Browse the full insider trade history of Telix Pharmaceuticals Limited, a listed equity based in Australia. Shares are listed on AU AU, under the supervision of ASX. Market capitalisation: €3.8bn. The latest transaction was reported on 11 May 2026 — Change in Substantial Holding. Among the most active insiders: There was a change in the interests of the. Every trade is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
14.26 €
Income statement
Revenue803.8 M€
Gross profit426.4 M€53% margin
Net income−7.1 M€-0.9% margin
Balance sheet & cash
Market cap3.79 Bn€
Total debt467.1 M€
Free Cash Flow−61.1 M€
Last declaration on 11 May 2026
Declarations2 total
Executives●Change in Substantial Holding2ASX
ShareASX
ASX:2924-03088915-3A693099·
Executives●Cease Substantial Holding2ASX
ShareASX
ASX:2924-03087348-3A692801·
2 of 2 declarations